Literature DB >> 18853449

Prognostic factors in malignancy of the minor salivary glands.

Kwok Seng Loh1, Emma Barker, Guillem Bruch, Brian O'Sullivan, Dale H Brown, David P Goldstein, Ralph W Gilbert, Patrick J Gullane, Jonathan C Irish.   

Abstract

BACKGROUND: The purpose of this study was to identify prognostic factors associated with minor salivary gland malignancies.
METHOD: This was a retrospective study of 171 patients. Statistical analysis of both clinical and pathological parameters with survival outcomes was performed.
RESULTS: Adenoid cystic carcinoma (46.8%), mucoepidermoid carcinoma (22.8%), and adenocarcinoma (18.7%) were the most common pathologies. The most frequent sites of primary tumor were in the oral cavity (44.4%) and nasal cavity (40.4%). The 5-year and 10-year overall survivals were 73.8% and 58.1%. Disease-specific survivals (DSS) were 78.2% and 66.7% and disease-free survivals (DFS) were 64.8% and 47.5%, respectively. Local recurrence rate was 26.9%, regional recurrence 7%, and distant failure was 18.7%. The grade of tumor was the only factor associated with DSS on multivariate analysis.
CONCLUSION: Overall and DSS of minor salivary gland malignancies were good. Surgery, either alone or in combination with radiation, was an efficacious treatment modality. High-grade tumors were associated with worse DSF. (c) 2008 Wiley Periodicals, Inc. Head Neck, 2009.

Entities:  

Mesh:

Year:  2009        PMID: 18853449     DOI: 10.1002/hed.20924

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  10 in total

1.  Minor salivary gland tumors of the head and neck-Memorial Sloan Kettering experience: Incidence and outcomes by site and histological type.

Authors:  Ashley J Hay; Jocelyn Migliacci; Daniella Karassawa Zanoni; Marlena McGill; Snehal Patel; Ian Ganly
Journal:  Cancer       Date:  2019-06-07       Impact factor: 6.860

2.  Sinonasal tract mucoepidermoid carcinoma: a clinicopathologic and immunophenotypic study of 19 cases combined with a comprehensive review of the literature.

Authors:  Erica B Wolfish; Brenda L Nelson; Lester D R Thompson
Journal:  Head Neck Pathol       Date:  2011-12-20

3.  The prognostic significance of β-catenin, cyclin D1 and PIN1 in minor salivary gland carcinoma: β-catenin predicts overall survival.

Authors:  Sven Schneider; Dietmar Thurnher; Rudolf Seemann; Markus Brunner; Lorenz Kadletz; Bahil Ghanim; Klaus Aumayr; Gregor Heiduschka; Claudia Lill
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-24       Impact factor: 2.503

4.  Radiation therapy in the treatment of minor salivary gland tumors.

Authors:  Lucas R Salgado; Daniel E Spratt; Nadeem Riaz; Paul B Romesser; Suzanne Wolden; Shyam Rao; Christine Chin; Julian C Hong; Richard Wong; Nancy Y Lee
Journal:  Am J Clin Oncol       Date:  2014-10       Impact factor: 2.339

5.  Sinonasal tract and nasopharyngeal adenoid cystic carcinoma: a clinicopathologic and immunophenotypic study of 86 cases.

Authors:  Lester D R Thompson; Carla Penner; Ngoc J Ho; Robert D Foss; Markku Miettinen; Jacqueline A Wieneke; Christopher A Moskaluk; Edward B Stelow
Journal:  Head Neck Pathol       Date:  2013-09-15

6.  Minor salivary gland carcinoma: a review of 35 cases.

Authors:  Georg Haymerle; Sven Schneider; Luke Harris; Theresia Häupl; Christian Schopper; Johannes Pammer; Matthaeus Ch Grasl; Boban M Erovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-10-23       Impact factor: 2.503

7.  Outcome analysis of 215 patients with parotid gland tumors: a retrospective cohort analysis.

Authors:  Boban M Erovic; Manish D Shah; Guillem Bruch; Meredith Johnston; U Johnston; John Kim; Brian O'Sullivan; Bayardo Perez-Ordonez; Ilan Weinreb; Eshetu G Atenafu; John R de Almeida; Patrick J Gullane; Dale Brown; Ralph W Gilbert; Jonathan C Irish; David P Goldstein
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-10-29

8.  Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?

Authors:  A D Jensen; M Poulakis; V Vanoni; M Uhl; N Chaudhri; P A Federspil; K Freier; J Krauss; J Debus
Journal:  Radiat Oncol       Date:  2016-07-07       Impact factor: 3.481

9.  Prognostic factors of palatal mucoepidermoid carcinoma: a retrospective analysis based on a double-center study.

Authors:  Wenguang Xu; Yufeng Wang; Xiaofeng Qi; Junqi Xie; Zheng Wei; Xiteng Yin; Zhiyong Wang; Jian Meng; Wei Han
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

10.  ELMO3 - a Negative Prognostic Marker in Minor Salivary Gland Carcinoma.

Authors:  Ulana Kotowski; Lorenz Kadletz; Sven Schneider; Felicitas Oberndorfer; Boban M Erovic; Matthaeus Ch Grasl; Claudia Lill; Gregor Heiduschka
Journal:  Pathol Oncol Res       Date:  2018-10-29       Impact factor: 3.201

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.